OBJECTIVES: To determine the underlying biochemical mechanisms responsible for the diminished viral replicative capacity associated with K65R/M184V-containing viruses. METHODS: We studied the efficiency of (-)ssDNA synthesis by recombinant wild-type and mutated HIV-1 reverse transcriptases in cell-free assays. In addition, we determined susceptibility levels to nucleoside analog reverse transcriptase inhibitors (NRTIs) both in cell-free and cell culture assays. RESULTS: We observed that the K65R/M184V mutations in reverse transcriptase caused reductions in the efficiency of initiation of (-)ssDNA synthesis by increasing pausing at positions +3 and +5 as well as diminished RNA usage. These findings were confirmed in cell culture data using MT-4 cells and cord blood mononuclear cells. CONCLUSIONS: The simultaneous presence of K65R and M184V in reverse transcriptase has a negative impact with regard to the efficiency of initiation of (-)ssDNA synthesis and RNA usage, that exceeds the effect of either mutation on its own. These mechanisms, among others, are responsible for the diminished viral replicative capacity observed in tissue culture when K65R/M184V-containing viruses are studied.
OBJECTIVES: To determine the underlying biochemical mechanisms responsible for the diminished viral replicative capacity associated with K65R/M184V-containing viruses. METHODS: We studied the efficiency of (-)ssDNA synthesis by recombinant wild-type and mutated HIV-1 reverse transcriptases in cell-free assays. In addition, we determined susceptibility levels to nucleoside analog reverse transcriptase inhibitors (NRTIs) both in cell-free and cell culture assays. RESULTS: We observed that the K65R/M184V mutations in reverse transcriptase caused reductions in the efficiency of initiation of (-)ssDNA synthesis by increasing pausing at positions +3 and +5 as well as diminished RNA usage. These findings were confirmed in cell culture data using MT-4 cells and cord blood mononuclear cells. CONCLUSIONS: The simultaneous presence of K65R and M184V in reverse transcriptase has a negative impact with regard to the efficiency of initiation of (-)ssDNA synthesis and RNA usage, that exceeds the effect of either mutation on its own. These mechanisms, among others, are responsible for the diminished viral replicative capacity observed in tissue culture when K65R/M184V-containing viruses are studied.
Authors: Philip M Grant; Jonathan Taylor; Andrew B Nevins; Vincent Calvez; Anne-Geneviève Marcelin; Marc Wirden; Andrew R Zolopa Journal: Antimicrob Agents Chemother Date: 2010-02-01 Impact factor: 5.191
Authors: Hong-Tao Xu; Susan P Colby-Germinario; Peter K Quashie; Richard Bethell; Mark A Wainberg Journal: Antimicrob Agents Chemother Date: 2015-03-16 Impact factor: 5.191
Authors: Dara A Lehman; Jared M Baeten; Connor O McCoy; Julie F Weis; Dylan Peterson; Gerald Mbara; Deborah Donnell; Katherine K Thomas; Craig W Hendrix; Mark A Marzinke; Lisa Frenkel; Patrick Ndase; Nelly R Mugo; Connie Celum; Julie Overbaugh; Frederick A Matsen Journal: J Infect Dis Date: 2015-01-13 Impact factor: 5.226
Authors: Alberto M La Rosa; Linda J Harrison; Babafemi Taiwo; Carole L Wallis; Lu Zheng; Peter Kim; Nagalingeswaran Kumarasamy; Mina C Hosseinipour; Bernadette Jarocki; John W Mellors; Ann C Collier Journal: Lancet HIV Date: 2016-04-18 Impact factor: 12.767
Authors: Julie F Weis; Jared M Baeten; Connor O McCoy; Chris Warth; Deborah Donnell; Katherine K Thomas; Craig W Hendrix; Mark A Marzinke; Nelly Mugo; Frederick A Matsen; Connie Celum; Dara A Lehman Journal: AIDS Date: 2016-01-02 Impact factor: 4.177